Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/14/15 → 07/13/17 |
Funding
- Gilead Sciences Incorporated: $6,625.00
A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia with 17p Deletion
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
Project: Research